Browse by Countries

Request/Offer Detail

Title: Dalbavancin
TypeName: Business Offer
Request Date:2017/09/26
Country: United States
Summary: Dalbavancin (INN, trade name Dalvance) is a novel second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin.The Food and Drug Administration approved dalbavancin for the treatment of acute bacterial skin and skin structure infections caused by certain susceptible bacteria.http://www.creative-peptides.com/product/dalbavancin-item-10-101-78-32.html
Description:
Advantages:
Comments:
RequestId: 504
Name:Caroline Miller
Telphone:
Email:contact@creative-peptides.com

Sponsors

smartportal sponsors